ORIC
ORIC Pharmaceuticals, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Jacob Chacko
IPO Date
2020-04-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
ORIC Pharmaceuticals, Inc.
CEO
Jacob Chacko
IPO Date
2020-04-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 52,000 |
| $4.36 |
| 26 Feb 2026 | Piscitelli Dominic | Chief Financial Officer | S-Sale | Disposed | 52,000 | $13.51 |
| 20 Jan 2026 | Heyman Richard A. | director | S-Sale | Disposed | 3,200 | $12.00 |
| 20 Jan 2026 | Heyman Richard A. | director | S-Sale | Disposed | 3,500 | $12.00 |
| 6 Jan 2026 | You Angie | director | A-Award | Acquired | 40,000 | $8.17 |
| 6 Jan 2026 | Kunkel Lori Anne | director | A-Award | Acquired | 40,000 | $8.17 |
| 6 Jan 2026 | Hoerter Steven L. | director | A-Award | Acquired | 40,000 | $8.17 |
| 6 Jan 2026 | Heyman Richard A. | director | A-Award | Acquired | 40,000 | $8.17 |
| 6 Jan 2026 | Dier Mardi | director | A-Award | Acquired | 40,000 | $8.17 |